News

A national poll finds few parents have their teens evaluated for heart disease, while gaps in training highlight ongoing challenges in responding to sudden cardiac arrest.

Nontargeted analysis identified 42 PFAS in cord blood, revealing broader prenatal exposure than traditional testing methods capture.

New international pediatric HAE guideline recommends oral sebetralstat as first-line acute therapy for adolescents 12 years and older.

A study found that 30 mg/kg/d methylprednisolone combined with tocilizumab was linked to improved neurological outcomes for encephalopathy.

A study found that rural birth hospitals experienced a net loss in higher-level neonatal services from 2010 to 2022, widening disparities with urban facilities.

FDA expands pitolisant indication to include cataplexy in patients 6 years and older with narcolepsy.

Ferric maltol gains FDA approval for children 10 years and older with iron deficiency, supported by phase 3 pediatric data.

New research demonstrates that targeted early intervention services improve academic performance and long-term health for children with developmental disabilities.

Meghan Drastal, MSN, MBA, RN, CPN, outlines CHLA’s data-driven strategies to improve workplace safety and pediatric de-escalation.

A study found persistently high rates of overweight and obesity in the United States, highlighting significant racial and ethnic disparities.

Open-label data show sustained seizure reduction, stable safety, and improved quality of life in LGS treated with fenfluramine.

A study found that a nirsevimab immunization program reduced RSV-related hospitalizations by 85.9% in the first season and 55.3% in the second.

National data suggest universal high ED pediatric readiness may prevent 2,143 child deaths annually at modest per-child cost.

Whole-genome sequencing revealed extensive NICU transmission of MSSA and MRSA strains linked to invasive infection.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

A study found no impact toward neurodevelopmental outcomes among toddlers exposed to mRNA COVID-19 vaccination in utero.

Host Brian Schroer, MD, interviews Sathya Areti, MD, about her case study presented at ACAAI 2025.

Host Brian Schroer, MD, interviews Melissa Ptak, DO, about her research presented at ACAAI 2025.

Experts review key updates to the 2025-2030 Dietary Guidelines for Americans and practical considerations for clinicians.

A new study finds high rates of neurodevelopmental diagnoses and service use among children undergoing heart surgery in infancy.

Phase trials show that Breztri Aerosphere triple therapy reduces annual severe exacerbation rates vs dual-combination inhaled therapy.

Quin Xie, PhD, and Jayne Danska, PhD, highlight increasing rates of type 2 diabetes in youth and suggest that measuring absolute gut bacterial abundance may improve risk prediction.

Part 4 highlights how expanding epinephrine delivery options can reduce barriers, support earlier administration, and improve real-world anaphylaxis outcomes.

In this segment, experts emphasize the importance of giving an infant experiencing anaphylaxis epinephrine at whatever dose may be available rather than delaying treatment.

In the second part of the special report, panelists delink epinephrine use from mandatory emergency department visits.

In the opening segment of this special report, panelists discuss updated anaphylaxis guidelines and early management priorities.

A study found that predischarge car seat tolerance screening was not associated with reduced 30-day mortality or hospital readmission among infants.

In the PROPEL 3 trial, oral infigratinib significantly increased annualized height velocity and improved body proportionality in children with achondroplasia.